Diagnostic marker for lung cancer comprising HPαR as active ingredient
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 15, 2014
Grant Date -
Jun 20, 2013
app pub date -
Jun 29, 2011
filing date -
Jun 29, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed is a diagnostic marker for lung cancer comprising HpαR as an active ingredient. Because blood, which is relatively easy to sample, is employed as a specimen, the diagnostic kit and marker for lung cancer is very simple and does not subject patients to a load compared to conventional methods that are directed to a biopsy. In addition, the kit and marker of the present invention is useful in the early diagnosis of lung cancer thanks to its high diagnostic sensitivity and selectivity.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully